VBLT Vascular Biogenics Ltd.

Vascular Biogenics Ltd is a clinical-stage bio-pharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

As of 04/14/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  10/01/2014
Outstanding shares:  48,187,463
Average volume:  485,544
Market cap:   $85,773,684
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    M96883109
Valuation   (See tab for details)
PE ratio:   -3.54
PB ratio:   2.77
PS ratio:   93.03
Return on equity:   -78.35%
Net income %:   -2,627.44%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy